Agilent Technologies Inc (A)
136.37
-1.12
(-0.81%)
USD |
NYSE |
Apr 25, 16:00
137.99
+1.62
(+1.19%)
Pre-Market: 20:00
Agilent Technologies Cash from Financing (Quarterly): -240.00M for Jan. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -240.00M |
| October 31, 2023 | -201.00M |
| July 31, 2023 | -322.00M |
| April 30, 2023 | -390.00M |
| January 31, 2023 | -17.00M |
| October 31, 2022 | -341.00M |
| July 31, 2022 | -362.00M |
| April 30, 2022 | -123.00M |
| January 31, 2022 | -546.00M |
| October 31, 2021 | -324.00M |
| July 31, 2021 | -222.00M |
| April 30, 2021 | 166.00M |
| January 31, 2021 | -316.00M |
| October 31, 2020 | -269.00M |
| July 31, 2020 | -231.00M |
| April 30, 2020 | -156.00M |
| January 31, 2020 | -61.00M |
| October 31, 2019 | 497.00M |
| July 31, 2019 | -582.00M |
| April 30, 2019 | -92.00M |
| January 31, 2019 | -122.00M |
| October 31, 2018 | -131.00M |
| July 31, 2018 | -589.00M |
| April 30, 2018 | -114.00M |
| January 31, 2018 | 37.00M |
| Date | Value |
|---|---|
| October 31, 2017 | -106.00M |
| July 31, 2017 | 29.00M |
| April 30, 2017 | -67.00M |
| January 31, 2017 | -58.00M |
| October 31, 2016 | -56.00M |
| July 31, 2016 | -105.00M |
| April 30, 2016 | 32.00M |
| January 31, 2016 | -139.00M |
| October 31, 2015 | -33.00M |
| July 31, 2015 | -127.00M |
| April 30, 2015 | -101.00M |
| January 31, 2015 | -828.00M |
| October 31, 2014 | 541.00M |
| July 31, 2014 | -518.00M |
| April 30, 2014 | -72.00M |
| January 31, 2014 | -68.00M |
| October 31, 2013 | 6.00M |
| July 31, 2013 | -332.00M |
| April 30, 2013 | -165.00M |
| January 31, 2013 | -63.00M |
| October 31, 2012 | 28.00M |
| July 31, 2012 | -7.00M |
| April 30, 2012 | -61.00M |
| January 31, 2012 | 3.00M |
| October 31, 2011 | -30.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-582.00M
Minimum
Jul 2019
497.00M
Maximum
Oct 2019
-206.60M
Average
-235.50M
Median
Cash from Financing (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | -200.62M |
| Revvity Inc | -19.61M |
| Bruker Corp | -59.90M |
| Azenta Inc | -113.15M |
| Harvard Bioscience Inc | -4.116M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 485.00M |
| Cash from Investing (Quarterly) | -95.00M |
| Free Cash Flow | 1.649B |
| Free Cash Flow Per Share (Quarterly) | 1.344 |
| Free Cash Flow to Equity (Quarterly) | 575.00M |
| Free Cash Flow to Firm (Quarterly) | 398.45M |
| Free Cash Flow Yield | 4.09% |